• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Pulmonary Embolism (1498); Chest Pain (1776); Dyspnea (1816)
Event Date 03/12/2019
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the patient's hospitalization.Since this event is associated with the treatment, this mdr will be against the instrument.From the instrument perspective, there was no known instrument malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.The distributor has their own biomed who performs all of the service for this instrument.Trends were reviewed for complaint categories, pulmonary embolism, chest pain, and shortness of breath.No trends were detected for these complaint categories.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: pulmonary embolism, chest pain, and dyspnea.(b)(4).S.K.(b)(6) 2019.
 
Event Description
The customer reported that an extracorporeal photopheresis (ecp) patient experienced a pulmonary embolism (pe) following a treatment procedure.The customer stated that the patient underwent a successful ecp treatment procedure using a peripheral access with acda as the anticoagulant at a 10:1 ratio on (b)(6) 2019.The customer reported that there were no alarms during this treatment procedure.The customer stated that the patient was stable throughout the treatment procedure and the patient's observations were within normal limits.The customer reported that the patient was well upon discharge post ecp.The customer stated that the patient was admitted eight days later on (b)(6) 2019 to another hospital.The customer reported that they did not have access to the patient's medical records as the patient was being treated at a different hospital, but they were informed that the patient was admitted for chest pain and shortness of breath.The customer reported that they were also informed that a ct pulmonary angiography confirmed a pulmonary embolism.The customer stated that they did not know if any medical intervention was provided to the patient since the patient was at a different hospital, though they did know that the patient was still in the hospital.The customer reported that despite the patient's pe, the patient's ecp treatment procedures had been improving the patient's lung function.The customer stated that the patient had not received any further treatment currently, but they intended to recommence the patient's ecp treatment procedures, possibly next week.The customer reported that it was unclear if the patient's ecp treatments procedures could have contributed to the patient's pe.However, the customer stated that it was possible that the patient's underlying condition may have contributed to their pe.No product was returned for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS
bedminster NJ
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key8510184
MDR Text Key141792544
Report Number2523595-2019-00053
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Nurse
Type of Report Initial
Report Date 04/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCELLEX
Device Lot NumberNOT APPLICABLE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/13/2019
Initial Date FDA Received04/12/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/13/2012
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age69 YR
Patient Weight93
-
-